Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

N/ATerminatedNCT02523066

Edwards Lifesciences215 enrolled

Overview

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.

Study Type

OBSERVATIONAL

Enrollment

215

Conditions

Mitral Valve or Aortic Valve Replacement

Interventions

Magna EaseDEVICE

This study is non-intervention

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * The patients who implanted with Magna Ease Heart Valve (Type:7300TFX and 3300TFX) in Fuwai Hospital in China. * The patients agree to sign the inform consent form (ICF). Exclusion Criteria: * No specific exclusion criteria.

Locations (1)

The Chinese academy of medical sciences fuwai hospital cardiovascular disease

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

Echocardiography to evaluate the performance of heart valve

Subjects are required to do eight times echocardiography in follow up visits

Time frame: Up to five years after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.